Correlation Between Pfizer and Berkshire Hathaway

Can any of the company-specific risk be diversified away by investing in both Pfizer and Berkshire Hathaway at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Berkshire Hathaway into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc CDR and Berkshire Hathaway CDR, you can compare the effects of market volatilities on Pfizer and Berkshire Hathaway and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Berkshire Hathaway. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Berkshire Hathaway.

Diversification Opportunities for Pfizer and Berkshire Hathaway

-0.44

Correlation Coefficient

Pfizer  Berkshire Hathaway

Very good diversification

The 3 months correlation between Pfizer and Berkshire is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Berkshire Hathaway CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Berkshire Hathaway CDR and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Berkshire Hathaway. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Berkshire Hathaway CDR has no effect on the direction of Pfizer i.e., Pfizer and Berkshire Hathaway go up and down completely randomly.

Pair Corralation between Pfizer and Berkshire Hathaway

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Berkshire Hathaway. In addition to that, Pfizer is 1.42 times more volatile than Berkshire Hathaway CDR. It trades about -0.09 of its total potential returns per unit of risk. Berkshire Hathaway CDR is currently generating about 0.0 per unit of volatility. If you would invest  3,441  in Berkshire Hathaway CDR on September 24, 2024 and sell it today you would lose (22.00) from holding Berkshire Hathaway CDR or give up 0.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc CDR  vs.  Berkshire Hathaway CDR

Pfizer Inc CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Berkshire Hathaway CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Berkshire Hathaway CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Berkshire Hathaway is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and Berkshire Hathaway

The main advantage of trading using opposite Pfizer and Berkshire Hathaway positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Berkshire Hathaway can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Berkshire Hathaway will offset losses from the drop in Berkshire Hathaway's long position.

The idea behind Pfizer Inc CDR and Berkshire Hathaway CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.